Y020-8883 Screening compound: N~1~-(2-fluoro-4-methylphenyl)-2-[2-oxo-1-(2-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]acetamide

Y020-8883 Screening compound: N~1~-(2-fluoro-4-methylphenyl)-2-[2-oxo-1-(2-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]acetamide
Y020-8883 Screening compound: N~1~-(2-fluoro-4-methylphenyl)-2-[2-oxo-1-(2-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-8883
N~1~-(2-fluoro-4-methylphenyl)-2-[2-oxo-1-(2-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-8883

Molecular Formula

C24H20FN5O2 (C24 H20 FN5 O2)

Compound Name

N~1~-(2-fluoro-4-methylphenyl)-2-[2-oxo-1-(2-pyridylmethyl)-2,3-dihydro-1H-imidazo[1,2-a][1,3]benzimidazol-3-yl]acetamide

IUPAC name

N-(2-fluoro-4-methylphenyl)-2-{4-oxo-5-[(pyridin-2-yl)methyl]-257-triazatricyclo[6.4.0.0^{26}]dodeca-1(12)6810-tetraen-3-yl}acetamide

SMILES

Cc(cc1)cc(F)c1NC(CC(C(N1Cc2ncccc2)=O)n2c1nc1c2cccc1)=O

InChI

InChI=1S/C24H20FN5O2/c1-15-9-10-18(17(25)12-15)27-22(31)13-21-23(32)29(14-16-6-4-5-11-26-16)24-28-19-7-2-3-8-20(19)30(21)24/h2-12,21H,13-14H2,1H3,(H,27,31)/t21-/m0/s1

InChI Key

IHOHGZPJZCRVBS-NRFANRHFSA-N

MDL Number (MFCD)

MFCD11852706

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

429.45

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.256

Distribution Coefficient, logD

3.231

Water Solubility, LogSw

-3.31

Polar Surface Area

58.133

Acid Dissociation Constant (pKa)

8.64

Base Dissociation Constant (pKb)

4.75

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

16.70

Y020-8883 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with Y020-8883 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-8883?
Check Price and Availability of Y020-8883, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-8883 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-8883
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-8883
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-8883 available by request